(Q28731914)

English

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis

scientific article (publication date: 2012)

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis (English)

0 references

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

object named as

Andrea Harrer

1

0 references

11

object named as

Eugen Trinka

0 references

Elisabeth Haschke-Becher

10

object named as

Elisabeth Haschke-Becher

0 references

author name string

Georg Pilz

2

0 references

Max Einhaeupl

3

0 references

Katrin Oppermann

4

0 references

Wolfgang Hitzl

5

0 references

Peter Wipfler

6

0 references

Johann Sellner

7

0 references

Stefan Golaszewski

8

0 references

Shahrzad Afazel

9

0 references

Joerg Kraus

12

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

2

0 references

e31784

0 references

copyright license

Creative Commons Attribution 4.0 International

20 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

17 March 2017

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

7 April 2017

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Antigen-specific therapies in MS - Current concepts and novel approaches.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

FcRn: the neonatal Fc receptor comes of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

The impact of interferon-beta treatment on the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Early development of therapeutic biologics--pharmacokinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282779

3 June 2018

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Differential expression of beta1 and beta2 integrins and L-selectin on CD4+ and CD8+ T lymphocytes in human blood: comparative analysis between isolated cells, whole blood samples and cryopreserved preparations.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

Natalizumab effects on immune cell responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

α4Integrins as Therapeutic Targets in Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031784

21 January 2018

CD49d expression as a promising biomarker to monitor natalizumab efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-alpha subtypes differentially affect human T cell motility

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab treatment reduces endothelial activity in MS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22363732

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0031784

0 references

2012PLoSO...731784H

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28731914&oldid=1868183008"